[Laboratory diagnosis in preventive cardiology]

Area of Science:

• Cardiology
• Preventive Medicine
• Clinical Lipidology

Context:

• Coronary artery disease (CAD) risk assessment relies on numerous identified factors.
• Current laboratory technologies provide estimates, not perfect predictions, of CAD events.
• Specialized laboratory tests and clinical data are essential for accurate risk stratification.

Purpose:

• To highlight the limitations of solely relying on lipid profiles for CAD risk assessment.
• To emphasize the importance of integrating clinical history, family history, and genetic factors.
• To introduce expert systems that combine laboratory values and clinical data for improved risk estimation.

Summary:

• While lipid levels (cholesterol, triglycerides, HDL, LDL, Lp(a)) inform many therapeutic decisions, they are insufficient alone for precise CAD risk prediction.
• Severe dyslipidemia, familial CAD, and unexplained CAD cases necessitate advanced work-ups.
• Accurate risk stratification requires a holistic approach, incorporating clinical data (hypertension, diabetes, smoking), family history, and genetics alongside lipid profiles.

Impact:

• Guides clinicians in judiciously applying specialized laboratory procedures.
• Supports the development and utilization of expert systems for personalized CAD risk management.
• Improves patient care by enabling more informed treatment recommendations based on comprehensive risk assessment.